Skip to main content
. 2023 Sep 11;13:15003. doi: 10.1038/s41598-023-40940-w

Figure 1.

Figure 1

Overview of the cohort and patient selection according to inclusion and exclusion criteria. MS multiple sclerosis; OCR ocrelizumab; PPMS primary progressive multiple sclerosis; EDSS expanded disability status scale.